Trial · NCT00088907
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Randomized Study (Step 1) | STARTED | Arm I (Docetaxel and Placebo) | 136 | |
| Randomized Study (Step 1) | STARTED | Arm II (Docetaxel and Gefitinib) | 134 | |
| Randomized Study (Step 1) | Treated | Arm I (Docetaxel and Placebo) | 129 | |
| Randomized Study (Step 1) | Treated | Arm II (Docetaxel and Gefitinib) | 124 | |
| Randomized Study (Step 1) | Eligible | Arm I (Docetaxel and Placebo) | 117 | |
| Randomized Study (Step 1) | Eligible | Arm II (Docetaxel and Gefitinib) | 122 | |
| Randomized Study (Step 1) | Eligible and Treated | Arm I (Docetaxel and Placebo) | 117 | |
| Randomized Study (Step 1) | Eligible and Treated | Arm II (Docetaxel and Gefitinib) | 122 | |
| Randomized Study (Step 1) | COMPLETED | Arm I (Docetaxel and Placebo) | 0 | |
| Randomized Study (Step 1) | COMPLETED | Arm II (Docetaxel and Gefitinib) | 0 | |
| Randomized Study (Step 1) | NOT COMPLETED | Arm I (Docetaxel and Placebo) | 136 | |
| Randomized Study (Step 1) | NOT COMPLETED | Arm II (Docetaxel and Gefitinib) | 134 | |
| Single Gefitinib Treatment (Step 2) | STARTED | Arm I (Docetaxel and Placebo) | 24 | |
| Single Gefitinib Treatment (Step 2) | STARTED | Arm II (Docetaxel and Gefitinib) | 0 | |
| Single Gefitinib Treatment (Step 2) | Treated | Arm I (Docetaxel and Placebo) | 19 | |
| Single Gefitinib Treatment (Step 2) | Treated | Arm II (Docetaxel and Gefitinib) | 0 | |
| Single Gefitinib Treatment (Step 2) | COMPLETED | Arm I (Docetaxel and Placebo) | 0 | |
| Single Gefitinib Treatment (Step 2) | COMPLETED | Arm II (Docetaxel and Gefitinib) | 0 | |
| Single Gefitinib Treatment (Step 2) | NOT COMPLETED | Arm I (Docetaxel and Placebo) | 24 | |
| Single Gefitinib Treatment (Step 2) | NOT COMPLETED | Arm II (Docetaxel and Gefitinib) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00088907/flow